Oslol-TR 80 Capsule contains Propranolol 80 mg, a non-selective beta-adrenergic receptor blocker used primarily in the management of cardiovascular conditions. Propranolol exerts its therapeutic effects by competitively inhibiting beta-1 and beta-2 adrenergic receptors, leading to decreased heart rate, myocardial contractility, and cardiac output, thereby reducing oxygen demand of the heart. It is indicated for the treatment of hypertension, angina pectoris, arrhythmias, and for the prevention of myocardial infarction. Additionally, Propranolol is utilized in the management of essential tremor, migraine prophylaxis, and certain types of anxiety disorders. Oslol-TR 80 Capsule is formulated as a sustained-release preparation to provide stable plasma concentrations and improve patient compliance through once or twice-daily dosing. The medication should be used with caution in patients with asthma, chronic obstructive pulmonary disease, diabetes mellitus, and peripheral vascular disease due to its non-selective beta-blocking activity. Common adverse effects include bradycardia, fatigue, dizziness, and gastrointestinal disturbances. It is contraindicated in patients with severe bradycardia, cardiogenic shock, and decompensated heart failure. Dose adjustments may be necessary in hepatic impairment. Oslol-TR 80 Capsule should be prescribed and monitored by healthcare professionals to ensure optimal therapeutic outcomes and patient safety.